微创介入治疗癌症晚期患者疼痛的
研究进展

doi:10.3760/cma.j.cn441417-20250609-15001

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (15): 2466-2470.DOI: 10.3760/cma.j.cn441417-20250609-15001

• 麻醉镇痛专栏 • 下一篇

微创介入治疗癌症晚期患者疼痛的研究进展

戴伟1 崔冬梅2 王文君3 杨文静4 马世刚5 张艳英6 王涛3 满涛7

1 枣庄市胸科医院（枣庄市肿瘤医院）外一科，滕州 277500；2 枣庄市胸科医院（枣庄市肿瘤医院）内一科，滕州 277500；3 枣庄市胸科医院（枣庄市肿瘤医院）微创介入病房，滕州 277500；4 枣庄市胸科医院（枣庄市肿瘤医院）内四科，滕州 277500；5 枣庄市胸科医院（枣庄市肿瘤医院）外二科，滕州 277500；6 枣庄市胸科医院（枣庄市肿瘤医院）检验科，滕州 277500；7 枣庄市胸科医院（枣庄市肿瘤医院）影像科，滕州 277500

收稿日期:2025-06-09 出版日期:2025-08-01 发布日期:2025-08-21
通讯作者: 杨文静，Email：515823168@qq.com
基金资助:
山东省医药卫生科技发展计划（202203020695）

Research progress of minimally invasive interventional therapy for pain in patients with advanced cancer

Dai Wei1 , Cui Dongmei2 , Wang Wenjun3 , Yang Wenjing4 , Ma Shigang5 , Zhang Yanying6 , Wang Tao3 , Man Tao7

1 Department of Surgery, Zaozhuang Chest Hospital (Zaozhuang Tumor Hospital), Tengzhou 277500, China; 2 Department of Internal Medicine, Zaozhuang Chest Hospital (Zaozhuang Cancer Hospital), Tengzhou 277500, China; 3 Minimally invasive interventional ward, Zaozhuang Chest Hospital (Zaozhuang Cancer Hospital), Tengzhou 277500, China; 4 Fourth department of Internal Medicine, Zaozhuang Chest Hospital (Zaozhuang Tumor Hospital), Tengzhou 277500, China; 5 Second Department of Surgery, Zaozhuang Chest Hospital (Zaozhuang Cancer Hospital), Tengzhou 277500, China; 6 Department of Laboratory, Zaozhuang Chest Hospital (Zaozhuang Cancer Hospital), Tengzhou 277500, China; 7Department of Imaging, Zaozhuang Chest Hospital (Zaozhuang Tumor Hospital), Tengzhou 277500, China

Received:2025-06-09 Online:2025-08-01 Published:2025-08-21
Contact: Yang Wenjing,Email:515823168@qq.com
Supported by:
Shandong Province Medical and Health Science and Technology Development Project （202203020695）

摘要/Abstract

摘要： 　癌性疼痛是癌症患者尤其是晚期癌症患者常见且严重影响生活质量的症状。传统药物治疗存在诸多局限性，微创介入治疗作为新兴手段在癌性疼痛管理中逐渐凸显优势。本文综述了微创介入治疗癌性疼痛患者的适应证和禁忌证、不同部位的常用方法（包括神经阻滞毁损术、经皮椎体成形术、射频消融术、鞘内药物输注系统植入术等在癌症晚期疼痛治疗中的应用）、难治性癌性疼痛的介入干预时机等，分析其原理、疗效、优势及相关风险，旨在为临床更好地选择和应用微创介入治疗癌性疼痛提供参考，以提高患者生存质量。

关键词: 癌性疼痛, 微创介入治疗, 进展

Abstract: Cancer pain is a common and severe symptom that significantly affects the quality of life of cancer patients, particularly those with advanced cancer. Traditional pharmacological treatments have many limitations; therefore, minimally invasive interventional therapies have gradually shown advantages in the management of cancer pain. This article reviews the indications and contraindications for minimally invasive interventional treatment in cancer pain patients, commonly used methods for different anatomical sites, including nerve block and ablation,percutaneous vertebroplasty, radiofrequency ablation, and intrathecal drug delivery system implantation for pain management in advanced cancer. It also discusses the timing of interventional interventions for refractory cancer pain, analyzing their principles, efficacy, advantages, and associated risks. The aim is to provide a reference for better selection and application of minimally invasive interventional therapies for cancer pain in clinical practice to improve patient quality of life.

Key words: Cancerous pain, Minimally invasive interventional therapy, Progress

戴伟崔冬梅王文君杨文静马世刚张艳英王涛满涛. 微创介入治疗癌症晚期患者疼痛的研究进展[J]. 国际医药卫生导报, 2025, 31(15): 2466-2470.

Dai Wei , Cui Dongmei , Wang Wenjun , Yang Wenjing , Ma Shigang , Zhang Yanying , Wang Tao , Man Tao. Research progress of minimally invasive interventional therapy for pain in patients with advanced cancer[J]. International Medicine and Health Guidance News, 2025, 31(15): 2466-2470.

参考文献

[1] Bhatnagar S, Gupta M. Evidence-based clinical practice guidelines for interventional pain management in cancer pain[J]. Indian J Palliat Care, 2015, 21(2): 137-147. DOI: 10.4103/0973-1075.156466.
[2] van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years[J]. Ann Oncol, 2007, 18(9): 1437-1449. DOI: 10.1093/annonc/mdm056.
[3] Mestdagh F, Steyaert A, Lavand'homme P. Cancer pain management: a narrative review of current concepts, strategies, and techniques[J]. Curr Oncol, 2023, 30(7): 6838-6858. DOI: 10.3390/curroncol30070500.
[4] Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain. a review of published literature[J]. Ann Oncol, 2008, 19(12):1985-1991. DOI: 10.1093/annonc/mdn419.
[5] Gaskin DJ, Richard P. The economic costs of pain in the United States[J]. J Pain, 2012, 13(8): 715-724. DOI: 10.1016/j.jpain.2012.03.009.
[6] 张鸣.不同初始剂量羟考酮缓释片在中重度癌痛控制中的疗效和安全性比较[D].济南: 济南大学,2019.
[7] 宋春雨,马云龙. 癌性疼痛相关微创介入治疗技术与应用进展[J]. 中国微创外科杂志,2019,19(7):626-629. DOI:10.3969/j.issn.1009-6604.2019.07.014.
[8] Trivedi M, Mathew J. Interventional treatments for cancer pain[J]. Cancer Treat Res, 2021, 182: 175-201. DOI: 10.1007/978-3-030-81526-4_12.
[9] 中国医师协会疼痛科医师分会,中华医学会疼痛学分会,国家疼痛专业医疗质量控制中心,等. 癌症相关性疼痛评估中国专家共识(2023版)[J]. 中国疼痛医学杂志,2023,29(12):881-886. DOI:10.3969/j.issn.1006-9852.2023.12.001.
[10] Vayne-Bossert P, Afsharimani B, Good P, et al. Interventional options for the management of refractory cancer pain--what is the evidence? [J]. Support Care Cancer, 2016, 24(3): 1429-1438. DOI: 10.1007/s00520-015-3047-4.
[11] WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents[S]. Geneva: World Health Organization, 2018.
[12] Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: American society of clinical oncology clinical practice guideline[J]. J Clin Oncol, 2016, 34(27): 3325-3345. DOI: 10.1200/JCO.2016.68.5206.
[13] Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO clinical practice guidelines[J]. Ann Oncol, 2018, 29 Suppl 4: iv166-iv191. DOI: 10.1093/annonc/mdy152.
[14] Swarm RA, Paice JA, Anghelescu DL, et al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(8): 977-1007. DOI: 10.6004/jnccn.2019.0038.
[15] Burton AW, Fanciullo GJ, Beasley RD, et al. Chronic pain in the cancer survivor: a new frontier[J]. Pain Med, 2007, 8(2): 189-198. DOI: 10.1111/j.1526-4637.2006.00220.x.
[16] van den Beuken-van Everdingen MHJ, van Kuijk SMJ, Janssen DJA, et al. Treatment of pain in cancer: towards personalised medicine[J]. Cancers (Basel), 2018, 10(12): 502. DOI: 10.3390/cancers10120502.
[17] 曾家华.经皮椎体成形术联合微波消融治疗脊柱转移瘤[D].南京: 南京医科大学,2023.DOI:10.27249/d.cnki.gnjyu.2023.000711.
[18] 樊刚,李波,袁涛,等. NRG1、VASH-1水平对ASO患者介入治疗后再狭窄的预测价值[J]. 保健医学研究与实践,2024,21(6):61-66. DOI:10.11986/j.issn.1673-873X.2024.06.11.
[19] Potter J, Higginson IJ, Scadding JW, et al. Identifying neuropathic pain in patients with head and neck cancer: use of the leeds assessment of neuropathic symptoms and signs scale[J]. J R Soc Med, 2003, 96(8): 379-383. DOI: 10.1177/014107680309600804.
[20] Grond S, Zech D, Diefenbach C, et al. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service[J]. Pain, 1996, 64(1): 107-114. DOI: 10.1016/0304-3959(95)00076-3.
[21] Ye Y, Jensen DD, Viet CT, et al. Advances in head and neck cancer pain[J]. J Dent Res, 2022, 101(9): 1025-1033. DOI: 10.1177/00220345221088527.
[22] 孟岚,任浩,赵春美,等. 射频热凝和脉冲射频治疗三叉神经痛疗效和安全性评价[J]. 中国疼痛医学杂志,2021,27(12):898-904. DOI:10.3969/j.issn.1006-9852.2021.12.004.
[23] 孙丽华,唐倩,顾光丽,等. 鞘内药物输注系统联合疼痛管理对居家中晚期重度疼痛癌症患者的治疗效果[J]. 贵州医科大学学报,2024,49(9):1353-1359. DOI:10.19367/j.cnki.2096-8388.2024.09.015.
[24] Gulati A, Shah R, Puttanniah V, et al. A retrospective review and treatment paradigm of interventional therapies for patients suffering from intractable thoracic chest wall pain in the oncologic population[J]. Pain Med, 2015, 16(4): 802-810. DOI: 10.1111/pme.12558.
[25] 刘洋.超声引导下改良肋间神经阻滞对乳腺癌改良根治术后镇痛效果的影响[D].合肥: 安徽医科大学,2024.DOI:10.26921/d.cnki.ganyu.2024.001355.
[26] 徐博,崔晓,宋辐,等.肋间神经前皮支联合肋间臂支阻滞对乳腺癌术后镇痛效果分析[J].中南医学科学杂志,2022,50(2):253-256.DOI:10.15972/j.cnki.43-1509/r.2022.02.024.
[27] 万营,曾晶磊,王志辉. 胸椎旁神经阻滞复合全身麻醉对肺癌根治术患者苏醒质量及疼痛程度的影响[J]. 癌症进展,2023,21(8):904-907. DOI:10.11877/j.issn.1672-1535.2023.21.08.24.
[28] Okita M, Otani K, Gibo N, et al. Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer[J]. Pain Pract, 2022, 22(7): 652-661. DOI: 10.1111/papr.13143.
[29] Ashlock K. Celiac plexus block: management of abdominal pain in patients with late-stage cancer[J]. Clin J Oncol Nurs, 2018, 22(6): 663-665. DOI: 10.1188/18.CJON.663-665.
[30] Liu Y, Zhang C, Song M, et al. Celiac plexus block combined with 125I seeds for refractory epigastric pain from abdominal malignancies: a retrospective case-control study[J]. Abdom Radiol (NY), 2023, 48(6): 2157-2166. DOI: 10.1007/s00261-023-03905-1.
[31] 张宇峰,周维纲,全志成. CT引导腹腔神经丛阻滞术在上腹部顽固性癌痛治疗中的应用[J]. 中国CT和MRI杂志,2019,17(12):117-119. DOI:10.3969/j.issn.16725131.2019.12.037.
[32] 孔鹏,苑天文,何阳,等. C型臂CT引导下经皮腹腔神经丛阻滞术在上腹部癌痛中的应用价值[J]. 介入放射学杂志,2020,29(10):1000-1003. DOI:10.3969/j.issn.1008-794X.2020.10.009.
[33] 孙亚鹏,沈利明,黄剑,等. 上腹下神经丛阻滞缓解子宫动脉栓塞后疼痛[J]. 中国介入影像与治疗学,2024,21(9):532-535. DOI:10.13929/j.issn.1672-8475.2024.09.005.
[34] Hou S, Novy D, Felice F, et al. Efficacy of superior hypogastric plexus neurolysis for the treatment of cancer-related pelvic pain[J]. Pain Med, 2020, 21(6): 1255-1262. DOI: 10.1093/pm/pnz151.
[35] 廖丽君,李顺,胡馨. CT引导下经椎间盘双针交叉入路上腹下神经丛阻滞术治疗顽固性盆腔癌痛的疗效观察[J]. 中华医学杂志,2013,93(37):2950-2952. DOI:10.3760/cma.j.issn.0376-2491.2013.37.009.
[36] 李娜,李敏,杨利珍,等. 鞘内输注氢吗啡酮与其联合氯胺酮和加巴喷丁治疗难治性癌痛的效果分析[J]. 临床药物治疗杂志,2024,22(3):43-49. DOI:10.3969/j.issn.1672-3384.2024.03.009.
[37] 杨威,胡婷业,陆玉和,等. 微波消融联合经皮椎体成形术治疗椎体转移性肿瘤的疗效观察[J]. 介入放射学杂志,2020,29(11):1146-1150. DOI:10.3969/j.issn.1008-794X.2020.11.018.
[38] Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: discussion of the current evidence and clinical implications[J]. J Opioid Manag, 2017, 13(2): 95-103. DOI: 10.5055/jom.2017.0373.
[39] 王志龙,林文俐,梁逸宁,等. 微波消融联合椎体成形术治疗脊柱转移瘤研究进展[J]. 介入放射学杂志,2023,32(4):404-409. DOI:10.3969/j.issn.1008-794X.2023.04.021.
[40] 吴细梅,伍晓员,牛国梁. 多学科合作团队综合管理模式对癌性疼痛患者的影响[J]. 当代护士(下旬刊),2022,29(4):136-139. DOI:10.19793/j.cnki.1006-6411.2022.12.040.
[41] 周春霞. 超声三维智能定位实时导航实用性的实验研究[D]. 大连:大连医科大学,2015.
[42] 罗卉.高分辨率MRI技术在盆底功能障碍及直肠肛管疾病精准评价中的应用[D].广州: 南方医科大学,2023.DOI:10.27003/d.cnki.gojyu.2023.000530.

微创介入治疗癌症晚期患者疼痛的研究进展

Research progress of minimally invasive interventional therapy for pain in patients with advanced cancer

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	赵洲刘为朋李宗睿王睿智胡宝光. 高血压大鼠模型的研究现状 [J]. 国际医药卫生导报, 2025, 31(9): 1465-1470.
[2]	昝兴淳. 通督调神针刺治疗脑卒中后吞咽障碍的研究进展与展望 [J]. 国际医药卫生导报, 2025, 31(9): 1470-1474.
[3]	李强. 超声引导下射频消融治疗甲状腺微小乳头状癌的研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1258-1260.
[4]	洪金全黄震宇黄惠炆黄豪博. 胸苷酸合成酶基因在肿瘤发生发展中的研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1260-1265.
[5]	蒋萌赵静如刘惠刘庆新. 自噬与缺血性脑血管疾病的研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1265-1269.
[6]	刘汉清孙银萍赵强任帅. MSI-H/dMMR亚组局部晚期结直肠癌患者新辅助免疫治疗研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1270-1274.
[7]	朱鹏唐文玲覃刚. 结直肠癌中微小RNA功能及临床价值进展 [J]. 国际医药卫生导报, 2025, 31(6): 886-890.
[8]	潘文昕姜伟炜. 结肠镜检查时机对缺血性结肠炎患者预后影响的研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 914-917.
[9]	张子怡孙大康. TRIM22抗HIV-1作用机制研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 918-922.
[10]	易伟米倩倩赵洁李博宇王丹. 彩色多普勒血流成像在球后血流动力学检测中的应用 [J]. 国际医药卫生导报, 2025, 31(6): 922-926.
[11]	陈秀珠张凯韦岩笑丛晨阳. 甲状腺相关眼病的药物治疗研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 927-929.
[12]	李晓童于胜强. 肾小管细胞来源外泌体在肾纤维化中的研究进展 [J]. 国际医药卫生导报, 2025, 31(5): 712-718.
[13]	张涵孙婷王延飞张肖林车娟. 移植后淋巴组织增生性疾病在儿童扁桃体腺样体肥大中的研究进展 [J]. 国际医药卫生导报, 2025, 31(5): 752-757.
[14]	莫家婵范万峰姜兴岳. 基于磁共振成像的影像组学在垂体腺瘤中的应用现状及进展 [J]. 国际医药卫生导报, 2025, 31(5): 757-760.
[15]	曾雅燕陈旭娜林彤彤谢漫郑智强蔡莹莹. 动机保护理论的健康教育模式在癌性疼痛患者疼痛全程管理中的应用 [J]. 国际医药卫生导报, 2025, 31(5): 860-864.

微创介入治疗癌症晚期患者疼痛的 研究进展

Research progress of minimally invasive interventional therapy for pain in patients with advanced cancer

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

微创介入治疗癌症晚期患者疼痛的研究进展